Iridex Corp
IRIX- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001006045
In the last 90 days, Iridex Corp insiders filed 4 open-market purchases and 0 sales; 29 institutions reported holding it in 13F filings for Q2 2026, worth $2.47M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Iridex Corp changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 30 | 29 | −1 |
| Shares | 3.32M | 3.28M | −41.2K (−1.2%) |
| Value | $9.90M | $7.08M | −$2.81M (−28.4%) |
New holders (2)
Institutions that held Iridex Corp at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bank of America Corp | 2,138 | $4.62K | 0.00% |
| Innealta Capital, LLC | 17 | $37 | 0.00% |
Sold out (3)
Institutions that held Iridex Corp at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Wolverine Trading, LLC | 16,279 | $48.5K |
| Morgan Stanley | 690 | $2.06K |
| Wells Fargo & Company | 98 | $292 |